Softbank Group Corp Pacific Biosciences Of California, Inc. Transaction History
Softbank Group Corp
- $28.7 Billion
- Q1 2025
A detailed history of Softbank Group Corp transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Softbank Group Corp holds 20,451,570 shares of PACB stock, worth $29.9 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
20,451,570
Previous 20,451,570
-0.0%
Holding current value
$29.9 Million
Previous $37.4 Million
35.52%
% of portfolio
0.08%
Previous 0.17%
Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
255Shares Held
227MCall Options Held
2.15MPut Options Held
967K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.5MShares$53.3 Million0.46% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$34.5 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$34.2 Million4.62% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.9MShares$31.9 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3MShares$23.7 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $328M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...